Predictive factors for central nervous system involvement in non-Hodgkin's lymphoma: Significance of very high serum LDH concentrations

Leukemia and Lymphoma

Volumn 38, Issue 3-4, 2000, Pages 335-343

  Tomita, Naoto ^a,b   Kodama, Fumio ^a   Sakai, Rika ^a   Koharasawa, Hideyuki ^a   Hattori, Michiko ^a   Taguchi, Jun ^a   Fujita, Hiroyuki ^a   Tanabe, Juichi ^a   Fujisawa, Shin ^a   Fukawa, Hitoshi ^a   Harano, Hiroshi ^a   Kanamori, Heiwa ^a   Miyashita, Hiroko ^a   Matsuzaki, Michio ^a   Ogawa, Koji ^a   Motomura, Sigeki ^a   Maruta, Atsuo ^a   Ishigatsubo, Yoshiaki ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b FUJIEDA MUNICIPAL GENERAL HOSPITAL   (Japan)

Author keywords

Central nervous system involvement; Non Hodgkin's lymphoma; Risk factors; Serum LDH concentration

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; FOLINIC ACID; LACTATE DEHYDROGENASE; METHOTREXATE; PREDNISOLONE; PREDNISONE; VINCRISTINE;

ARTICLE; CANCER RISK; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM METASTASIS; CLINICAL TRIAL; DIAGNOSTIC VALUE; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PREDICTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 17044456227     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009087024     Document Type: Article

References (16)

1. Herman, T.S., Hammond, N., Jones, S.E., Butler, J.J., Byrne, G.E. and McKelvey, E.M. (1979) Involvement of the central nervous system by non-Hodgkin's lymphoma. Cancer, 43, 390-397.
2. Johnson, G.J., Oken, M.M., Anderson, J.R., O'Connell, M.J. and Glick, J. H. (1984) Central nervous system relapse in unfavourable-histology non-Hodgkin's lymphoma: Is prophylaxis indicated? Lancet, 685-687.
3. Ersboll, J., Schultz, H.B., Thomsen, B.L., Keiding, N. and Nissen, N.I. (1985) Meningeal involvement in non-Hodgkin's lymphoma: symptoms, incidence, risk factors and treatment. Scandinavian Journal of Haematology, 35, 487-496.
4. Law, I.P., Dick, F.R., Blom, J. and Bergevin, P.R. (1975) Involvement of the central nervous system in non-Hodgkin's lymphoma. Cancer, 36, 225-231.
5. Bollen, E.L., Brouwer, R.E., Hamers, S., Hermans, J., Kluin, M., Sankatsing, S.U., A-Tjak, R.V., Charvat, M.V. and Kluin-Nelemans, J. C. (1997) Central nervous system relapse in non-Hodgkin lymphoma. A single-center study of 532 patients. Archives of Neurology, 54, 854-859.
6. Levitt, L.J., Dowson, D.M., Rosenthal, D.S. and Moloney, W.C. (1980) CNS involvement in the non-Hodgkin's lymphomas. Cancer, 45, 545-552.
7. Keldsen, N., Michalski, W., Bentzen, S.M., Hansen, K.B. and Thorling, K. (1996) Risk factors for central nervous system involvement in non-Hodgkins-lymphoma - a multivariate analysis. Acta Oncologica, 35, 703-708.
8. Recht, L., Straus, D.J., Cirrincione, C., Thaler, H.T. and Posner J.B. (1988) Central nervous system metastases from non-Hodgkin's lymphoma: treatment and prophylaxis. American Journal of Medicine 84, 425-435.
9. Liang, R., Chiu, E. and Loke, S.L. (1990) Secondary central nervous system involvement by non-Hodgkin's lymphoma: the risk factors. Hematological Oncology, 8, 141-145.
10. Litam, J.P., Cabanillas, F., Smith, T.L., Bodey, G.P. and Freireich, E. J. (1979) Central nervous system relapse in malignant lymphomas: Risk factors and implications for prophylaxis. Blood, 54, 1249-1257.
11. Bashir, R.M., Bierman, P.J., Vose, J.M., Weisenburger, D.D. and Armitage, J.O. (1991) Central nervous system involvement in patients with diffuse aggressive non-Hodgkin's lymphoma. American Journal of Clinical Oncology 14, 478-482.
12. Besien, K., Ha, C.S., Murphy, S., McLaughlin, P., Rodrigues, A., Amin, K., Forman, A., Romaguera, J., Hagemeister, F., Younes, A., Bachier, C., Sarris, A., Sobocinski, K.S., Cox, J.D. and Cabanillas, F. (1998) Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma. Blood, 91, 1178-1184.
13. MacKintosh, F.R., Colby, T.V., Podolsky, W.J., Burke, J.S., Hoppe, R. T., Rosenfelt, F.P., Rosenberg, S.A. and Kaplan, H.S. (1982) Central nervous system involvement in non-Hodgkin's lymphoma: an analysis of 105 cases. Cancer, 49, 586-595.
14. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. (1993): A predictive model for aggressive non-Hodgkin's lymphoma. New England Journal of Medicine, 329, 987-994.
15. The Non-Hodgkin's Lymphoma Pathologic Classification Project. (1982) National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer, 49, 2112-2135.
16. Coleman, C.N., Picozzi, V.J., Cox, R.S., McWhirter, K., Weiss, L.M., Cohen, J.R., Yu, K.P. and Rosenberg, S.A. (1986) Treatment of lymphoblastic lymphoma in adults. Journal of Clinical Oncology, 4, 1628-1637.